Shanghai Allist Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Shanghai Allist Pharmaceuticals has a total shareholder equity of CN¥4.3B and total debt of CN¥1.3M, which brings its debt-to-equity ratio to 0.03%. Its total assets and total liabilities are CN¥4.7B and CN¥379.7M respectively. Shanghai Allist Pharmaceuticals's EBIT is CN¥926.8M making its interest coverage ratio 1078.7. It has cash and short-term investments of CN¥2.7B.
Key information
0.03%
Debt to equity ratio
CN¥1.27m
Debt
| Interest coverage ratio | 1078.7x |
| Cash | CN¥2.68b |
| Equity | CN¥4.32b |
| Total liabilities | CN¥379.72m |
| Total assets | CN¥4.70b |
Recent financial health updates
No updates
Recent updates
Shanghai Allist Pharmaceuticals Co., Ltd. (SHSE:688578) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected
Apr 30
Should You Be Adding Shanghai Allist Pharmaceuticals (SHSE:688578) To Your Watchlist Today?
Apr 01Optimistic Investors Push Shanghai Allist Pharmaceuticals Co., Ltd. (SHSE:688578) Shares Up 26% But Growth Is Lacking
Mar 04Financial Position Analysis
Short Term Liabilities: 688578's short term assets (CN¥3.1B) exceed its short term liabilities (CN¥373.2M).
Long Term Liabilities: 688578's short term assets (CN¥3.1B) exceed its long term liabilities (CN¥6.5M).
Debt to Equity History and Analysis
Debt Level: 688578 has more cash than its total debt.
Reducing Debt: 688578's debt to equity ratio has reduced from 35.1% to 0.03% over the past 5 years.
Debt Coverage: 688578's debt is well covered by operating cash flow (40989.9%).
Interest Coverage: 688578's interest payments on its debt are well covered by EBIT (1078.7x coverage).